Quarterly report pursuant to sections 13 or 15(d)

Document and Entity Information

v2.3.0.11
Document and Entity Information
3 Months Ended
Mar. 31, 2012
May 01, 2012
Document and Entity Information [Abstract]    
Entity Registrant Name Atlas Therapeutics Corp  
Entity Central Index Key 0001402479  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Mar. 31, 2012
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q1  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   79,938,997